| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PLoSO..1017599B |
| P356 | DOI | 10.1371/JOURNAL.PONE.0117599 |
| P8608 | Fatcat ID | release_ptfxowaaxne5ffa4gqab4obbze |
| P932 | PMC publication ID | 4334531 |
| P698 | PubMed publication ID | 25680200 |
| P5875 | ResearchGate publication ID | 273953345 |
| P50 | author | Henkjan J Verkade | Q99400886 |
| Frank A J A Bodewes | Q114525914 | ||
| P2093 | author name string | Hugo R de Jonge | |
| Annette S H Gouw | |||
| Willemien de Vries | |||
| Marcel J Bijvelds | |||
| Juul F W Baller | |||
| P2860 | cites work | The phosphatidylethanolamine N-methyltransferase pathway is quantitatively not essential for biliary phosphatidylcholine secretion | Q80535952 |
| Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration | Q83154070 | ||
| Outcome in Cystic Fibrosis Liver Disease | Q84800550 | ||
| Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. | Q42555482 | ||
| Defects in gallbladder emptying and bile Acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies. | Q43008641 | ||
| Regulation of cholangiocyte secretion | Q44165090 | ||
| Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events | Q45140576 | ||
| Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells | Q45866124 | ||
| Production of a severe cystic fibrosis mutation in mice by gene targeting | Q45868497 | ||
| Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice | Q45884139 | ||
| Human hepatic mitochondria generate reactive oxygen species and undergo the permeability transition in response to hydrophobic bile acids | Q46628330 | ||
| Eradication of small intestinal bacterial overgrowth in the cystic fibrosis mouse reduces mucus accumulation | Q46872811 | ||
| Ursodeoxycholate modulates bile flow and bile salt pool independently from the cystic fibrosis transmembrane regulator (Cftr) in mice | Q48190174 | ||
| The role of bile salt composition in liver pathology of mdr2 (-/-) mice: differences between males and females. | Q50956249 | ||
| Regulation of bile acid synthesis. III. Correlation between biliary bile salt hydrophobicity index and the activities of enzymes regulating cholesterol and bile acid synthesis in the rat | Q69701876 | ||
| Natural history of liver disease in cystic fibrosis | Q73114499 | ||
| Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver | Q73491970 | ||
| Cystic fibrosis-associated liver disease: a population-based study | Q80517955 | ||
| Promotion of liver regeneration/repair by farnesoid X receptor in both liver and intestine in mice | Q24626582 | ||
| A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION | Q25939000 | ||
| A simple and sensitive assay of total serum bile acids | Q28333896 | ||
| Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein | Q28593082 | ||
| FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways | Q28741802 | ||
| Identification of the cystic fibrosis gene: genetic analysis | Q29614402 | ||
| A single centre experience of liver disease in adults with cystic fibrosis 1995-2006. | Q33377573 | ||
| Pathophysiological preconditions promoting mixed "black" pigment plus cholesterol gallstones in a DeltaF508 mouse model of cystic fibrosis | Q33994808 | ||
| Cholangiocyte biology and cystic fibrosis liver disease | Q34464126 | ||
| Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model | Q35097413 | ||
| Dose-response of five bile acids on serum and liver bile Acid concentrations and hepatotoxicty in mice | Q35231059 | ||
| Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice | Q35269164 | ||
| Impaired mucosal barrier function in the small intestine of the cystic fibrosis mouse | Q35281958 | ||
| Cystic fibrosis: molecular biology and therapeutic implications | Q35319385 | ||
| Prevalence of liver disease in cystic fibrosis | Q35626850 | ||
| Regulation of membrane chloride currents in rat bile duct epithelial cells | Q35824120 | ||
| Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis | Q35834086 | ||
| Animal models of cystic fibrosis | Q35908456 | ||
| Effect of antibiotic treatment on fat absorption in mice with cystic fibrosis. | Q37206368 | ||
| FXR: a metabolic regulator and cell protector | Q37282312 | ||
| Hepatobiliary disease in patients with cystic fibrosis | Q37452650 | ||
| The biliary HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies | Q37781024 | ||
| Mouse models of cystic fibrosis: phenotypic analysis and research applications | Q37887172 | ||
| Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease | Q37887181 | ||
| p38 MAPK: a dual role in hepatocyte proliferation through reactive oxygen species | Q38125809 | ||
| Hepatobiliary pathology in patients with cystic fibrosis | Q38790995 | ||
| A mouse model for the cystic fibrosis delta F508 mutation. | Q40789334 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0117599 | |
| P577 | publication date | 2015-02-13 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Cholic acid induces a Cftr dependent biliary secretion and liver growth response in mice | |
| P478 | volume | 10 |
| Q97905953 | Early pathogenesis of cystic fibrosis gallbladder disease in a porcine model |
| Q39044713 | Hepatostat: Liver regeneration and normal liver tissue maintenance |
| Q92985260 | Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2-/- mice |
| Q93013565 | Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice |
| Q57118966 | Paternal cholestasis exacerbates obesity-associated hypertension in male offspring but is prevented by paternal ursodeoxycholic acid treatment |
| Q91919553 | Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota |
Search more.